Guy Taylor

Guy Taylor
T: +44 (0) 20 7246 0524
E: guy.taylor@alantra.com

Guy is a Director in our Debt Capital Markets team. He works with both corporate clients and financial sponsors helping them access both new sources of debt capital and manage existing debt facilities.

Recent deals include advising Lonsdale Capital Partners on its majority investment in Charles Cameron & Associates; Gladman Developments on a £100m debt refinance; advising on the management buy-outs of Lawyers on Demand, Jollyes Retail Group, and Addo Food Group; advising Rutland Partners on its acquisition of Armitage Pet Care; the investment in Global Freight Solutions by Phoenix Equity Partners; advising Waterland Private Equity Investments on the refinancing of Ballast Phoenix; and advising on the acquisition of Santia by Alcumus.  

Prior to Alantra, Alantra Guy spent seven years in banking, working in corporate acquisition finance and sponsor leveraged finance. Guy was previously a Director in the mid-market leverage team at CIT Bank where he focused primarily on transaction values between £50m and £250m.

Guy qualified as a Chartered Accountant in 2004 and also has an MBA from Manchester Business School.

When he’s not working, Guy is a keen motorcyclist, mountain biker and loves to ski.

 

 

Alantra appoints experienced partner to head up its UK Real Estate & Hospitality team

Alantra has appointed Hoong Wey Woon as a Partner to head up its UK Real Estate & Hospitality team.  

Alantra advises Strong Roots on securing over €15.5m of investment

Alantra advises Strong Roots, one of the UK’s fastest-growing food companies, on securing over €15.5m of investment 

Alantra advises i2S on its sale to Gfi Informatique

Alantra advises Portuguese IT firm, i2S, on its sale to Gfi Informatique 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.